Deutsche Bank’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Deutsche Bank’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-3	Closed	–	–	5615
2016 Q2	$0	Buy	+3	New	+$5	﹤0.01%	5641
2015 Q2	–	Sell	-6,056	Closed	-$54K	–	5690
2015 Q1	$54K	Buy	6,056 +3,476	+135%	+$27.9K	﹤0.01%	4366
2014 Q4	$14K	Buy	+2,580	New	+$13.5K	﹤0.01%	5647

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Deutsche Bank's EPRS Position: Q3 2016 in Review

Deutsche Bank sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 3 shares.

Deutsche Bank first reported a position in EPRS in Q4 2014 and held it in 3 quarters. The position peaked at $54K in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Deutsche Bank reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Deutsche Bank sold 3 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016.
Deutsche Bank first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q4 2014 and held it in 3 quarters.
Deutsche Bank's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $54K in Q1 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Deutsche Bank's 13F filing for Q3 2016, filed 14 Nov 2016.